You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Calpain 3 antibody - Domain II (catalytic domain), large subunit
See all Calpain 3 products (13) ...

Description

Rabbit polyclonal to Calpain 3 - Domain II (catalytic domain), large subunit

Specificity

The antibody does not cross react with the other calpain family members (m-calpain, M-calpain, LP-82/85 Calpain, ncl-2, ncl-3, etc.). The antibody may crossreact with rat 88 and 90 kD novel Calpains due to Domain II sequence similarities.

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat

Immunogen

Synthetic peptide based on Insert 1, in domain-II of human Calpain 3 large subunit. (Peptide available as ab41306.)

General notes

EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen (94 kDa form).

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962)Western blot - Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab38962 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: A recommended starting concentration for Western blots is 1:1000 when using colorimetric substrates such as BCIP/NBT, and 1:5000 for chemiluminescent substrates. Higher concentrations of antibody may be needed for samples from more distantly related species. When used against the reduced protein, Ab38962 identifies bands at 94 Kd, 82 Kd, 62 Kd, 60 Kd, and a series of further cleaved active forms. EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. Dilution optimised using Chromogenic detection. Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Calcium-regulated non-lysosomal thiol-protease.

Tissue specificity

Isoform I is skeletal muscle specific.

Involvement in disease

Defects in CAPN3 are the cause of limb-girdle muscular dystrophy type 2A (LGMD2A) [MIM:253600]. LGMD2A is an autosomal recessive degenerative myopathy characterized by progressive symmetrical atrophy and weakness of the proximal limb muscles and elevated serum creatine kinase. The symptoms usually begin during the first two decades of life, and the disease gradually worsens, often resulting in loss of walking ability 10 or 20 years after onset.

Sequence similarities

Belongs to the peptidase C2 family.
Contains 1 calpain catalytic domain.
Contains 4 EF-hand domains.

Cellular localization

Cytoplasm.

Target information above from: UniProt accessionP20807 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Calcium activated neutral proteinase 3 antibody
  • Calcium activated neutral proteinase 3 antibody
  • Calcium-activated neutral proteinase 3 antibody
  • Calpain L3 antibody
  • Calpain large polypeptide L3 antibody
  • Calpain large polypeptide L3 antibody
  • Calpain p94 antibody
  • Calpain-3 antibody
  • CAN3_HUMAN antibody
  • CANP 3 antibody
  • CANP3 antibody
  • CANPL3 antibody
  • CAPN 3 antibody
  • CAPN3 antibody
  • LGMD 2A antibody
  • LGMD2 antibody
  • LGMD2A antibody
  • Limb girdle muscular dystrophy 2A antibody
  • Limb girdle muscular dystrophy 2A antibody
  • Lp82 antibody
  • LP85 antibody
  • Muscle specific calcium activated neutral protease 3 antibody
  • Muscle-specific calcium-activated neutral protease 3 antibody
  • nCL-1 antibody
  • nCL1 antibody
  • New calpain 1 antibody
  • p94 antibody
see all

Anti-Calpain 3 antibody - Domain II (catalytic domain), large subunit images:

  Western blot - Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962)

Western blot - Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962)

All lanes : Anti-Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962) at 1 µg/ml

Lane 1 : SHSY-5Y (Human neuroblastoma cell line) Whole Cell Lysate
Lane 2 : HCT 116 (Human Colorectal Carcinoma) Whole Cell Lysate

Lysates/proteins at 10 µg per lane.

Secondary
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size : 94 kDa
Observed band size : 100 kDa (why is the actual band size different from the predicted?)

References for Anti-Calpain 3 antibody - Domain II (catalytic domain), large subunit (ab38962)

This product has been referenced in:

  • Moretti Det al. Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis 30:960-7 (2009).Read more (PubMed: 19386580) »

See 1 publication for this product

Publishing research using ab38962? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"